Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2325 of 3173 entries
View as:

First-in-Human Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of Janus Kinase-1 Inhibitor PF-04965842 in Healthy Western and Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01835197 Org: User:
Start: 05/31/13 End: 06/30/14 Due: 06/30/15

Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)

Phase: N/A Priority: Normal
NCT ID: NCT00313781 Org: User:
Start: 05/31/06 End: 12/31/11 Due: 12/31/12

Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee

Phase: N/A Priority: Normal
NCT ID: NCT02697773 Org: User:
Start: 01/21/16 End: 05/14/18 Due: 05/14/19

Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition

Phase: N/A Priority: Normal
NCT ID: NCT01445067 Org: User:
Start: 11/30/11 End: 09/30/12 Due: 09/30/13

An Open-Label Pharmacokinetics and Safety Study of Talazoparib

Phase: N/A Priority: Normal
NCT ID: NCT02997163 Org: User:
Start: 02/21/17 End: 01/30/19 Due: 01/30/20

Maraviroc in Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00427934 Org: User:
Start: 02/28/07 End: 10/31/08 Due: 10/31/09

A Real-world, Prospective Observational Study of Rimegepant ODT for the Acute Treatment of Migraine Attacks in Adults.

Phase: N/A Priority: Normal
NCT ID: NCT06467370 Org: User:
Start: 07/02/24 End: 03/11/25 Due: 03/11/26

Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)

Phase: N/A Priority: Normal
NCT ID: NCT01521897 Org: User:
Start: 09/30/10 End: 04/30/15 Due: 04/30/16

A Study Of The Safety And Efficacy Of PF-04191834 In Patients With Osteoarthritis Of The Knee

Phase: N/A Priority: Normal
NCT ID: NCT01147458 Org: User:
Start: 07/31/10 End: 02/28/11 Due: 02/28/12

Food Effect Study For Apixaban Commercial Image Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01437839 Org: User:
Start: 09/30/11 End: 10/31/11 Due: 10/31/12

A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated Diarrhea

Phase: N/A Priority: Normal
NCT ID: NCT00650637 Org: User:
Start: 01/31/03 End: 08/31/03 Due: 08/31/04

Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan)

Phase: N/A Priority: Normal
NCT ID: NCT01230177 Org: User:
Start: 05/31/11 End: 04/30/13 Due: 04/30/14

Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients

Phase: N/A Priority: Normal
NCT ID: NCT04071405 Org: User:
Start: 05/12/20 End: 09/26/22 Due: 09/26/23

A Study Evaluating The Safety Of PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-06)

Phase: N/A Priority: Normal
NCT ID: NCT02015156 Org: User:
Start: 01/31/14 End: 04/30/14 Due: 04/30/15

A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking Metformin

Phase: N/A Priority: Normal
NCT ID: NCT02053116 Org: User:
Start: 03/31/14 End: 04/30/14 Due: 04/30/15

Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00038467 Org: User:
Start: 02/28/98 End: 03/31/13 Due: 03/31/14

A Long-Term Safety And Tolerability Study Of Bapineuzumab In Alzheimer Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT00996918 Org: User:
Start: 12/31/09 End: 11/30/12 Due: 11/30/13

Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00974311 Org: User:
Start: 09/30/09 End: 11/02/17 Due: 11/02/18

A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00977522 Org: User:
Start: 11/30/09 End: 09/30/10 Due: 09/30/11

Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00139711 Org: User:
Start: 03/31/03 End: 06/30/06 Due: 06/30/07

Study Of PF-06410293 And Adalimumab In Healthy Subjects (REFLECTIONS B538-01)

Phase: N/A Priority: Normal
NCT ID: NCT01870986 Org: User:
Start: 05/31/13 End: 02/28/14 Due: 02/28/15

Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.

Phase: N/A Priority: Normal
NCT ID: NCT00140062 Org: User:
Start: 02/28/02 End: 04/30/06 Due: 04/30/07

Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01500551 Org: User:
Start: 03/18/13 End: 02/12/25 Due: 02/12/26

Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)

Phase: N/A Priority: Normal
NCT ID: NCT00620074 Org: User:
Start: 08/31/08 End: 02/28/09 Due: 02/28/10

Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01010542 Org: User:
Start: 12/01/09 End: 05/20/11 Due: 05/20/12